Remove 2020 Remove BioTech Remove Health Policy Remove Pharmaceuticals
article thumbnail

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Health Populi

The economic and healthcare system impacts of this were explored in the Post-Covid Healthcare Landscape , delivered by Fitch Solutions’ Jamie Davies and Beau Noafshar, leaders in the Pharmaceuticals, Healthcare, and Medical Devices groups.

BioTech 270
article thumbnail

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Health Populi

The coolest thing in health policy in the 21st century!! ” Amitabh Chandra gave the opening context-setting talk about the effects of health care cost-sharing on patients-as-consumers. have struggled to pay for living expenses since December 2020, a year into the COVID-19 pandemic.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

When asked what factors contribute to rising health care costs in America, most consumers cite the cost of prescription drugs. approaches the 2020 Presidential election. patients’ negative views of the pharmaceutical industry in this study was the opioid epidemic. The Physicians Foundation surveyed 2,001 U.S.

article thumbnail

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Health Populi

” I’ve pulled out a few of the data points that speak to me about population health, prevention and early diagnosis (or lack thereof), and alarm bells on women’s health — notably, young women and girls.

article thumbnail

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Health Populi

. “A therapy is useless if no one can afford it,” asserted Cathryn Donaldson from AHIP, the health insurance advocacy group, quoted in the story. ” The politics of prescription drug pricing will continue to be personal for health care voters, I forecast in my own scenarios looking toward not 2023 — but 2020.

Medicare 149
article thumbnail

The Remarkable Rise of Pharma’s Reputation in the Pandemic

Health Populi

The reputation of the pharmaceutical industry gained a “whopping” 30 points between January 2020 and February 2021, based on the latest Harris Poll in their research into industries’ reputations. consumers trusted the biotech health industry segment compared with the pharmaceutical segment.

article thumbnail

Americans Across Political Party Worry About Prescription Drug Prices – Especially to Deal with COVID-19

Health Populi

The Gallup-West Health Poll finds similar massive support for government negotiation specifically for COVID-19 treatment pricing, shown in the third table. Gallup and West Health polled 1,016 U.S. adults 18 and older, in English and Spanish, in May 2020. CMS defines specialty drugs as therapies with monthly costs over $670.

BioTech 191